Bausch Health Companies Inc (BHC)

Feb 21, 2025, 1:33 PM EST - 1 day ago

Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room

Feb 20, 2025, 6:01 PM EST - 2 days ago

Bausch Health Q4 Earnings Recap (Reiterating Buy Rating)

Feb 19, 2025, 8:28 PM EST - 3 days ago

Bausch Health Companies Inc. (BHC) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 4:05 PM EST - 3 days ago

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

Feb 19, 2025, 6:58 AM EST - 3 days ago

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

Feb 14, 2025, 8:00 AM EST - 8 days ago

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Feb 12, 2025, 5:41 AM EST - 10 days ago

Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

Feb 10, 2025, 8:00 AM EST - 12 days ago

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Feb 6, 2025, 7:27 AM EST - 16 days ago

Contact lens maker Bausch + Lomb rules out take-private deal

Feb 6, 2025, 7:05 AM EST - 16 days ago

Bausch Health Provides Update on Strategic Alternatives

BLCO

Feb 6, 2025, 7:00 AM EST - 16 days ago

Bausch + Lomb Provides Update on Potential Sale

Jan 23, 2025, 7:00 AM EST - 4 weeks ago

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Jan 22, 2025, 7:00 AM EST - 4 weeks ago

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Jan 17, 2025, 9:25 AM EST - 5 weeks ago

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Jan 14, 2025, 2:15 PM EST - 5 weeks ago

Bausch + Lomb CEO on the negative impact of screen time on eye health

Jan 14, 2025, 12:24 PM EST - 5 weeks ago

Bausch and Lomb CEO: Right on track with our important initiatives

Jan 13, 2025, 7:00 AM EST - 5 weeks ago

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America

Jan 13, 2025, 7:00 AM EST - 5 weeks ago

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Jan 13, 2025, 6:00 AM EST - 5 weeks ago

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Jan 10, 2025, 8:30 AM EST - 6 weeks ago

InflammX Therapeutics Announces Option Agreement with Bausch + Lomb

Jan 10, 2025, 8:00 AM EST - 6 weeks ago

Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine

Jan 10, 2025, 6:00 AM EST - 6 weeks ago

City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy

Jan 9, 2025, 9:00 AM EST - 6 weeks ago

Outcome Capital Congratulates Elios Vision on the Acquisition by Bausch + Lomb

Jan 7, 2025, 7:00 AM EST - 6 weeks ago

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge

Jan 2, 2025, 7:00 AM EST - 7 weeks ago

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 12, 2024, 2:18 PM EST - 2 months ago

Contact lens maker Bausch + Lomb says it is exploring sale

Dec 12, 2024, 7:00 AM EST - 2 months ago

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Dec 12, 2024, 7:00 AM EST - 2 months ago

Bausch + Lomb Responds to Rumors of a Potential Sale

Dec 11, 2024, 8:46 AM EST - 2 months ago

Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

M PLAY

Dec 11, 2024, 6:59 AM EST - 2 months ago

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Dec 6, 2024, 7:30 PM EST - 2 months ago

Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News

Dec 5, 2024, 8:00 AM EST - 2 months ago

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

Dec 2, 2024, 10:21 PM EST - 2 months ago

Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors

Dec 2, 2024, 8:00 AM EST - 2 months ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Nov 18, 2024, 9:49 AM EST - 3 months ago

US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug

Nov 18, 2024, 8:00 AM EST - 3 months ago

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Nov 18, 2024, 8:00 AM EST - 3 months ago

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

Nov 14, 2024, 7:00 AM EST - 3 months ago

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Oct 30, 2024, 9:17 PM EDT - 4 months ago

Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:05 PM EDT - 4 months ago

Bausch Health Announces Third Quarter 2024 Results

NHC

Oct 30, 2024, 7:00 AM EDT - 4 months ago

Bausch + Lomb Announces Third-Quarter 2024 Results

Oct 27, 2024, 12:15 PM EDT - 4 months ago

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

Oct 14, 2024, 10:04 AM EDT - 4 months ago

Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces

TPG BX

Oct 14, 2024, 7:00 AM EDT - 4 months ago

Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens

Oct 9, 2024, 4:05 PM EDT - 4 months ago

Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024

Oct 9, 2024, 8:00 AM EDT - 4 months ago

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

Oct 8, 2024, 8:00 AM EDT - 4 months ago

Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises

Oct 1, 2024, 7:00 AM EDT - 5 months ago

Bausch + Lomb Launches Opal™ Digital Marketplace in the United States

Sep 19, 2024, 4:51 PM EDT - 5 months ago

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

Sep 19, 2024, 7:30 AM EDT - 5 months ago

With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels